Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Low Incidence of Chronic Graft-Versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Using Matched Related or Unrelated Donors: Phase II Study Interim Analysis

Blood (2021) 138 (Supplement 1): 1811.

https://doi.org/10.1182/blood-2021-147569

Published: 2021

Journal Articles

Phase 2 Results of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor As Treatment for Life-Threatening Acute Gvhd

Blood (2021) 138 (Supplement 1): 261.

https://doi.org/10.1182/blood-2021-145008

Published: 2021

Journal Articles

Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A Phase I Study

Blood (2018) 132 (Supplement 1): 71.

https://doi.org/10.1182/blood-2018-99-113564

Published: 2018

Journal Articles

Alternative donor hematopoietic cell transplantation for Fanconi anemia

Margaret L. MacMillan, Todd E. DeFor, Jo-Anne H. Young, Kathryn E. Dusenbery, Bruce R. Blazar, Arne Slungaard, Heather Zierhut, Daniel J. Weisdorf, John E. Wagner

Blood (2015) 125 (24): 3798–3804.

https://doi.org/10.1182/blood-2015-02-626002

Published: 2015

Journal Articles

Heme Potently Stimulates Tissue Factor Expression By Peripheral Blood Monocytes: A Novel Mechanism For Thrombosis In Intravascular Hemolytic Diseases

Teena Rehani, Ph.D., Kristin Mathson, B.S., John D Belcher, Ph.D., Gregory M Vercellotti, Arne Slungaard, MD

Blood (2013) 122 (21): 2215.

https://doi.org/10.1182/blood.V122.21.2215.2215

Published: 2013

Journal Articles

Thiocyanate Blocks Peroxidase-Dependent Extracellular Trap (ET) Formation By PMN and Eosinophils: Heme Is a Potent New Agonist For The ET Pathway

Kristin Mathson, B.S., Rehani Teena, Ph.D., John D Belcher, Ph.D., Gregory M Vercellotti, Arne Slungaard, MD

Blood (2013) 122 (21): 323.

https://doi.org/10.1182/blood.V122.21.323.323

Published: 2013

Journal Articles

Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia.

Margaret L. MacMillan, MD, Bruce R. Blazar, MD, Todd E. Defor, MS, Kathryn E. Dusenbery, MD, Arne Slungaard, MD, Michael R. Verneris, MD, Jo-Anne H. Young, MD, Heather Zierhut, PhD, Daniel J. Weisdorf, MD, John E. Wagner, MD

Blood (2012) 120 (21): 3081.

https://doi.org/10.1182/blood.V120.21.3081.3081

Published: 2012

Journal Articles

The Major Phagocyte Peroxidase Product HOSCN Stimulates PMN and Eosinophil Adhesion to Endothelium by p38 MAPK-Dependent Enhancement of CD11b/18-ICAM-1 Binding,

Adria Jonas, M.S., Teena Rehani, Ph.D., Arne Slungaard, MD

Blood (2011) 118 (21): 3205.

https://doi.org/10.1182/blood.V118.21.3205.3205

Published: 2011

Journal Articles

The Major Phagocyte Peroxidase-Derived Oxidant HOSCN Stimulates Gene-Specific p38 MAPK- Dependent, NF-κb-Mediated Activation of Tissue Factor, VCAM-1 and ICAM-1 Expression In Endothelium.

Teena Rehani, Ph.D., Adria Jonas, M.S., Arne Slungaard, MD

Blood (2010) 116 (21): 1481.

https://doi.org/10.1182/blood.V116.21.1481.1481

Published: 2010

Journal Articles

The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice

Robert P. Hebbel, Gregory M. Vercellotti, Betty S. Pace, Anna N. Solovey, Rahn Kollander, Chine F. Abanonu, Julia Nguyen, Julie V. Vineyard, John D. Belcher, Fuad Abdulla, Shadé Osifuye, John W. Eaton, Robert J. Kelm, Jr, Arne Slungaard

Blood (2010) 115 (12): 2483–2490.

https://doi.org/10.1182/blood-2009-02-204990

Published: 2010

Journal Articles

The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease.

Robert P Hebbel, MD, Gregory M. Vercellotti, MD, Betty Pace, MD, Anna Solovey, M.D., Rahn Kollander, Chine Abanonu, Julia Nguyen, BS, Julie V. Vineyard, BS, John D Belcher, Ph.D., Fuad Abdulla, Shade Osifuye, John W. Eaton, PhD, Robert Kelm, MD, Arne Slungaard, MD

Blood (2009) 114 (22): 2586.

https://doi.org/10.1182/blood.V114.22.2586.2586

Published: 2009

Journal Articles

Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: Similar Efficacy of Non-Myeloablative and Myeloablative Conditioning; Long-Term Evaluation From the University of Minnesota.

Brian McClune, DO, Linda J. Burns, MD, Todd E. DeFor, MS, Arne Slungaard, MD, Veronika Bachanova, Claudio Brunstein, MD, PhD, Daniel J. Weisdorf

Blood (2009) 114 (22): 3385.

https://doi.org/10.1182/blood.V114.22.3385.3385

Published: 2009

Journal Articles

Gene-Specific Effects of the Histone Deacetylase Inhibitor TSA on Activation of a Pro-Inflammatory Endothelial Cell Phenotype by the Major Phagocyte Peroxidase-Derived Oxidant HOSCN.

Teena Pasrija, Ph.D., Shawn A Mahmud, Ph.D., John D Belcher, Ph.D., Gregory M. Vercellotti, MD, Arne Slungaard, MD

Blood (2008) 112 (11): 1274.

https://doi.org/10.1182/blood.V112.11.1274.1274

Published: 2008

Journal Articles

The Major Phagocyte Peroxidase-Derived Oxidant, HOSCN (Hypothiocyanous Acid), Induces Proinflammatory and Cytoprotective Gene Expression in Endothelium: A Mechanism for Microlocalized Regulation of Inflammation.

Shawn A. Mahmud, BA, Jian-Guo Wang, Ph.D., Peng Wei, M.S., Molly S. Thomas, Ph.D., John D. Belcher, Ph.D., Gregory M. Vercellotti, M.D., Arne Slungaard, M.D.

Blood (2007) 110 (11): 3295.

https://doi.org/10.1182/blood.V110.11.3295.3295

Published: 2007

Journal Articles

Reduced Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor.

Navneet S. Majhail, Claudio Brunstein, John E. Wagner, Marcie Tomblyn, Avis Thomas, Jeffrey S. Miller, Mukta Arora, Dan S. Kaufman, Linda J. Burns, Arne Slungaard, Philip B. McGlave, Daniel J. Weisdorf

Blood (2007) 110 (11): 331.

https://doi.org/10.1182/blood.V110.11.331.331

Published: 2007

Journal Articles

Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone

Jeffrey S. Miller, Daniel J. Weisdorf, Linda J. Burns, Arne Slungaard, John E. Wagner, Michael R. Verneris, Sarah Cooley, Rosanna Wangen, Susan K. Fautsch, Roby Nicklow, Todd DeFor, Bruce R. Blazar

Blood (2007) 110 (7): 2761–2763.

https://doi.org/10.1182/blood-2007-05-090340

Published: 2007

Journal Articles

Endogenous platelet factor 4 stimulates activated protein C generation in vivo and improves survival after thrombin or lipopolysaccharide challenge

M. Anna Kowalska, Shawn A. Mahmud, Michele P. Lambert, Mortimer Poncz, Arne Slungaard

Blood (2007) 110 (6): 1903–1905.

https://doi.org/10.1182/blood-2007-03-081901

Published: 2007

Journal Articles

Lymphodepletion Followed by Donor Lymphocyte Infusions (DLI) Causes Significantly More Acute Graft Versus Host Disease Than DLI Alone.

Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Linda J. Burns, MD, Arne Slungaard, MD, John E. Wagner, MD, Michael R. Verneris, MD, Sarah Cooley, MD, Rosanna Wangen, Susan K. Fautsch, Roby Nicklow, Todd DeFor, Bruce R. Blazar

Blood (2006) 108 (11): 260.

https://doi.org/10.1182/blood.V108.11.260.260

Published: 2006

Journal Articles

“TF-kB”-Dependent Suppression of Agonist-Mediated Tissue Factor Induction by Histone Deacetylase Inhibitors in Human Endothelial Cells and Monocytes.

Jianguo Wang, PhD, Shawn A. Mahmud, B.A., Peter B. Bitterman, M.D., Yuqing Huo, M.D., Ph.D., Arne Slungaard, M.D.

Blood (2006) 108 (11): 1745.

https://doi.org/10.1182/blood.V108.11.1745.1745

Published: 2006

Journal Articles

Release of High Levels of Platelet Factor 4 (PF4) from Platelets Improves Survival after a Lethal Lipopolysaccharide (LPS) Challenge.

M. Anna Kowalska, PhD, Michele P. Lambert, MD, Lubica Rauova, MD, PhD, William J. Smith, BS, Shawn A. Mahmud, BS, Mortimer Poncz, MD, Arne Slungaard, MD

Blood (2006) 108 (11): 61.

https://doi.org/10.1182/blood.V108.11.61.61

Published: 2006

NARROW

Low Incidence of Chronic Graft-Versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Using Matched Related or Unrelated Donors: Phase II Study Interim Analysis

Phase 2 Results of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor As Treatment for Life-Threatening Acute Gvhd

Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A Phase I Study

Alternative donor hematopoietic cell transplantation for Fanconi anemia

Heme Potently Stimulates Tissue Factor Expression By Peripheral Blood Monocytes: A Novel Mechanism For Thrombosis In Intravascular Hemolytic Diseases

Thiocyanate Blocks Peroxidase-Dependent Extracellular Trap (ET) Formation By PMN and Eosinophils: Heme Is a Potent New Agonist For The ET Pathway

Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia.

The Major Phagocyte Peroxidase Product HOSCN Stimulates PMN and Eosinophil Adhesion to Endothelium by p38 MAPK-Dependent Enhancement of CD11b/18-ICAM-1 Binding,

The Major Phagocyte Peroxidase-Derived Oxidant HOSCN Stimulates Gene-Specific p38 MAPK- Dependent, NF-κb-Mediated Activation of Tissue Factor, VCAM-1 and ICAM-1 Expression In Endothelium.

The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice

The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease.

Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: Similar Efficacy of Non-Myeloablative and Myeloablative Conditioning; Long-Term Evaluation From the University of Minnesota.

Gene-Specific Effects of the Histone Deacetylase Inhibitor TSA on Activation of a Pro-Inflammatory Endothelial Cell Phenotype by the Major Phagocyte Peroxidase-Derived Oxidant HOSCN.

The Major Phagocyte Peroxidase-Derived Oxidant, HOSCN (Hypothiocyanous Acid), Induces Proinflammatory and Cytoprotective Gene Expression in Endothelium: A Mechanism for Microlocalized Regulation of Inflammation.

Reduced Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor.

Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone

Endogenous platelet factor 4 stimulates activated protein C generation in vivo and improves survival after thrombin or lipopolysaccharide challenge

Lymphodepletion Followed by Donor Lymphocyte Infusions (DLI) Causes Significantly More Acute Graft Versus Host Disease Than DLI Alone.

“TF-kB”-Dependent Suppression of Agonist-Mediated Tissue Factor Induction by Histone Deacetylase Inhibitors in Human Endothelial Cells and Monocytes.

Release of High Levels of Platelet Factor 4 (PF4) from Platelets Improves Survival after a Lethal Lipopolysaccharide (LPS) Challenge.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only